Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program
Asensus Surgical (NYSE American: ASXC) announced that LKH-Universitätsklinikum Graz in Austria has agreed to lease and use a Senhance® Surgical System. This marks the second hospital in Austria and the 7th pediatric-focused site to adopt this technology. The hospital, renowned for minimally invasive pediatric and adolescent surgery, will utilize the system's 3mm and 5mm instruments for various procedures.
Professor Holger Till, Head of Pediatric and Adolescent Surgery at the hospital, expressed excitement about the partnership, highlighting the potential of Senhance's small instruments to enhance surgical outcomes for young patients. Asensus Surgical's CEO, Anthony Fernando, emphasized the collaboration's role in expanding the adoption of their innovative surgical platform globally.
- Expansion of Senhance Surgical System to a new hospital in Austria
- Adoption by a renowned institution specializing in pediatric and adolescent surgery
- Potential for enhanced surgical outcomes in young patients due to 3mm instruments
- None.
Insights
The adoption of the Senhance Surgical System by LKH-Universitätsklinikum Graz is a significant step forward in the field of minimally invasive pediatric surgery. The utilization of 3mm and 5mm instruments is particularly notable, as these smaller instruments can reduce trauma and promote faster recovery times for young patients. This aligns with the growing trend of favoring minimally invasive techniques in the medical community.
The expertise of LKH-Universitätsklinikum Graz in pediatric surgery further validates the potential of the Senhance system. As the second hospital in Austria to adopt this technology, it shows a growing acceptance and trust in the system's capabilities. This move can potentially influence other hospitals to consider similar advancements, thus expanding the market for Asensus Surgical.
However, it is essential to consider the practical outcomes over time. The real test will be in the clinical results and patient outcomes, which will determine the long-term success and adoption of this technology.
Investors should monitor the clinical data and feedback from the medical community to gauge the system's effectiveness and potential market expansion.
From a market perspective, the collaboration with LKH-Universitätsklinikum Graz represents a strategic expansion for Asensus Surgical. Establishing a presence in a reputable European hospital can enhance credibility and open doors to other international markets. The fact that this is the seventh pediatric-focused site to adopt the Senhance system highlights a growing niche market within pediatric surgical care.
Given that pediatric surgeries require specialized, delicate approaches, the unique features of the Senhance system, such as the 3mm instruments, can be a competitive advantage. However, it's important for Asensus to maintain high standards and deliver consistent results to sustain growth and attract further interest from other institutions.
In the short term, this announcement may positively impact Asensus Surgical's stock due to the perceived market expansion and innovative application of their technology. Long-term investors should look at how this collaboration translates into broader adoption and revenue growth.
Becomes the second hospital in Austria to utilize Senhance
RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement to lease and utilize a Senhance® Surgical System.
LKH-Universitätsklinikum Graz is a renowned healthcare institution known for its expertise in minimally invasive pediatric and adolescent surgery. This hospital will be the 7th pediatric-focused site to utilize the state-of-the-art Senhance Surgical System using 3mm and 5mm instruments for a variety of minimally invasive procedures.
“We are thrilled to collaborate with LKH-Universitätsklinikum Graz for the initiation of our Senhance Surgical System clinical program,” said Anthony Fernando, Asensus Surgical President and CEO. “This collaboration demonstrates our commitment to expanding the adoption of our innovative surgical platform to benefit patients and healthcare providers around the world.”
"We are excited to partner with Asensus Surgical and incorporate the Senhance Surgical System into our clinical practice," said Professor Holger Till, Head of the Department of Pediatric and Adolescent Surgery at LKH-Universitätsklinikum Graz. "The Senhance System is the first platform to offer 3mm instruments. These small instruments have the potential to enhance surgical outcomes for our young patients, and we look forward to advancing the field of pediatric and adolescent surgery with this cutting-edge platform.”
The Senhance Surgical System is being recognized as an advanced robotic option for pediatric procedures
About LKH-Universitätsklinikum Graz
LKH-Universitätsklinikum Graz is a leading healthcare institution located in Graz, Austria, with a reputation for excellence in medical care, research, and education. The hospital is affiliated with the Medical University of Graz and serves as a prominent center for healthcare delivery, innovation, and academic excellence in the region. LKH-Universitätsklinikum Graz has a comprehensive Department of Pediatric and Adolescent Surgery specializing in providing surgical care for infants, children, and adolescents with a wide range of conditions. The highly skilled and experienced team of surgeons utilizes advanced surgical techniques and state-of-the-art technology to deliver exceptional care and optimize patient outcomes. As a leading institution in Austria, LKH-Universitätsklinikum Graz is committed to advancing the field of pediatric and adolescent surgery through continuous research, innovation, and collaboration with global partners. The hospital is dedicated to providing the highest standard of care to its patients, while also serving as a center for education and training for the next generation of healthcare professionals. With a strong focus on patient-centric care, cutting-edge technology, and interdisciplinary collaboration, LKH-Universitätsklinikum Graz strives to improve the health and well-being of its patients, contribute to scientific advancement, and shape the future of healthcare in Austria and beyond.
About Asensus Surgical, Inc.
Asensus Surgical is revolutionizing surgery with the first intra-operative Augmented Intelligence technology approved for use in operating rooms around the world. Recognized as an award-winning leader in digital technology, Asensus is committed to making surgery more accessible and predictable while delivering consistently superior outcomes. The Company’s novel approach to digitizing laparoscopy has led to system placements globally. Led by engineers, medical professionals, and industry luminaries, Asensus is powered by human ingenuity and driven by collaboration. To learn more about Asensus, visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc/
X: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/@AsensusSurgical
TikTok:https://www.tiktok.com/@asensus_surgical
Forward-Looking Statements
This press release includes statements relating to the Senhance Surgical System and LKH-Universitätsklinikum Graz initiating a program with the Senhance System. These statements and other statements regarding our future plans and goals constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations and include whether the collaboration with LKH-Universitätsklinikum Graz demonstrates our commitment to expanding the adoption of the Senhance System platform to benefit patients and healthcare providers around the world and whether the Senhance System will help LKH-Universitätsklinikum Graz advance the field of pediatric and adolescent surgery. For a discussion of the risks and uncertainties associated with the Company’s business, please review our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 22, 2024 and our other filings we make with the SEC. You are cautioned not to place undue reliance on these forward looking statements, which are based on our expectations as of the date of this press release and speak only as of the origination date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
INVESTOR CONTACT:
Mark Klausner or Mike Vallie
ICR Westwicke
invest@asensus.com
443-213-0499
MEDIA CONTACT:
Dan Ventresca
Matter Communications
AsensusPR@matternow.com
617-874-5488
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4ebdba83-fc59-45a4-b5ba-853de6b43d0e
FAQ
What hospital in Austria has agreed to use Asensus Surgical's Senhance System (ASXC)?
How many pediatric-focused sites are now using the Senhance Surgical System (ASXC)?
What unique feature does the Senhance System (ASXC) offer for pediatric surgeries?
Who is the Head of Pediatric and Adolescent Surgery at LKH-Universitätsklinikum Graz partnering with Asensus Surgical (ASXC)?
